Inexpensive test, treatment for syphilis could save nearly 1M infants annually

NewsGuard 100/100 Score

An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports. "A team of researchers led by Rosanna Peeling and David Mabey at the [London School of Hygiene & Tropical Medicine (LSHTM)] found in a study due to be published soon that introducing rapid tests to increase access to syphilis screening was both feasible and cost effective," the news agency writes.

According to experts, more than two million pregnant women are infected with syphilis each year, and more than half pass the infection on to their infants, Reuters notes, adding that in Africa, the disease causes nearly 400,000 stillbirths and infant deaths annually. The syphilis partnership includes the Bill & Melinda Gates Foundation, Save the Children, the WHO, the CDC and the LSHTM, according to the news agency (Kelland, 2/29).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
JYNNEOS vaccine shows strong effectiveness against Mpox in New York outbreak